Joined December 2017
- Tweets 42
- Following 53
- Followers 127
- Likes 34
Photos and videos
Pinned Tweet
8 Dec 2020
Thanks to the amazing Iana Meitlis who is in UW Med school, Eric Allenspach, Andrew Snow and Dave Rawlings. These methods were based on work by @jshendure, @lea_starita, @TheNobleDust
2
Richard G. James retweeted
9 Nov 2022
Please take a look at this manuscript in collaboration with @ScienceRicker that also shows one should not make an assumption that transcript # is correlated to secretion of a protein. biorxiv.org/content/10.1101/…
1
8
19
Richard G. James retweeted
26 Oct 2022
New research published in @NatureComms from our co-founders Drs. @ScienceRicker and David Rawlings from @seattlechildren shows robust protein production and long-term engraftment of engineered plasma B cells. nature.com/articles/s41467-0… #BeBio #SCRI #Research #BCells
6
13
Richard G. James retweeted
18 Oct 2022
Very happy to see the full story out finally. We had been sitting on some of these exciting findings since 2017! (6/6)
1
1
Richard G. James retweeted
1 Sep 2022
A really cool application of Partillion Biosciences and @10xGenomics technologies to measure secreted proteins together with single cell gene expression.
26 Aug 2022
SEC-seq: Association of molecular signatures with antibody secretion in thousands of single human plasma cells biorxiv.org/cgi/content/shor… #bioRxiv
14
54
Richard G. James retweeted
14 Apr 2022
Congratulations to @bebiopharma on the Series B! This Longwood-founded company is making progress in developing a new class of cellular medicines to help patients.
14 Apr 2022
Today we announced the closing of a $130 million financing round led by ARCH Venture Partners. The funds will support our mission to unleash the power of B cells to drive a new class of cellular medicines.
Read more in our press release: bit.ly/37LI3Sn
2
6
Richard G. James retweeted
7 Mar 2022
Bianca Viray, a professor @UW, has been awarded the AMS Joan and Joseph Birman Fellowship for Women Scholars for the 2022–2023 academic year. An arithmetic geometer, Viray researches rational points on varieties.
➡ bit.ly/3sOzka9
ALT AMS Birman Fellowship, Bianca Viray.
8
16
71
Richard G. James retweeted
18 Jan 2022
Join our team!
DIRECTOR OF MUTATIONAL SCANNING
This person will lead a team to help bring mutational scanning methods to production scale. Terrific job opportunity with @JShendure @lea_starita
Details and how to apply here: bit.ly/3tpPdVo
6
6
Richard G. James retweeted
14 Dec 2021
Until the pre-print posts, I figured I would put together a thread for those who want to see the data. Many thanks to @wilfredo_nk, @kstdenis29, @EvanCLam, @adamnitido, @NaranbhaiVivek who have been up at all hours of the night both at the bench and writing the paper!
1/16
23
347
962
Richard G. James retweeted
29 Nov 2021
Today we release in @biorxivpreprint a method for isolating megabase-sized, oncogenic extrachromosomal DNA from human cancer cells. A collaboration with @HowardYChang, @Jens_Luebeck, @RaeisiSiavash, Vineet Bafna, @mischellab and others. (1/n) biorxiv.org/content/10.1101/…
1
28
100
Richard G. James retweeted
24 Nov 2021
Our paper is out in @Nature! Extrachromosomal DNA molecules huddle together in cancer cells to activate oncogene expression (which we call ecDNA hubs). A great collaboration with @KatieEYost, @HowardYChang, @549nm, Zhe Liu, and others. (1/10) nature.com/articles/s41586-0…
10
152
552
Richard G. James retweeted
22 Nov 2021
B cells are nature’s medicine factories built to unleash a variety of therapeutic applications. Hear our scientific co-founders, Richard James (@ScienceRicker) & David Rawlings describe the incredible versatility of B cells.
vimeo.com/646051754
2
9
Richard G. James retweeted
29 Sep 2021
Introducing NextTrevor, an open-source project to harness publicly available images of @trvrb. We provide a continually-updated view of @trvrb's evolution alongside powerful analytic tools. Our goal is to aid understanding and improve response to changes in his appearance.
11
45
542
Richard G. James retweeted
28 Jun 2021
Congrats to the hubs, @ScienceRicker, for cofounding @bebiopharma, over zoom, while simultaneously home schooling 6th grade! Exciting technology for the sustained delivery of protein therapeutics. Read more here ⬇️
24 Jun 2021
Our annual survey of some of the best #NBTAcademicStartups in 2020 continues with @bebiopharma, which turns plasma cells into protein factories for patients with protein deficiencies for whom one-and-done gene therapy is not an option nature.com/articles/d41587-0…
3
20
Richard G. James retweeted
3 Jul 2021
Check out our paper —>
1 Jul 2021
Our paper on sci-Space, a spatially resolved version of sci-RNA-seq, is out today!
Led by @srsrivatsan and @mregier13, Joint work with @JShendure and @kellystevenslab. (Art by @nigelsussman)
1
11
118
28 Jun 2021
Your work started @kinglhung - we are super excited to keep it moving forward!
28 Jun 2021
So glad to see that this is gaining traction!
1
Richard G. James retweeted
25 Jun 2021
Thanks for featuring @bebiopharma Longwood-founded #celltherapy #newco nature.com/articles/d41587-0…
24 Jun 2021
Our annual survey of some of the best #NBTAcademicStartups in 2020 continues with @bebiopharma, which turns plasma cells into protein factories for patients with protein deficiencies for whom one-and-done gene therapy is not an option nature.com/articles/d41587-0…
5
8
15 Apr 2021
Excited to share our functional data that has helped classify VUS associated with immune dysregulation at #CIS2021 - what a great meeting! Check it out
3
Richard G. James retweeted
16 Mar 2021
Thrilled to announce the appointment of Joanne Smith-Farrell and Rick Morgan to the leadership team at Be Bio!
businesswire.com/news/home/2…
6
9
Richard G. James retweeted
18 Mar 2021
In new work led by @AllieGreaney, we analyze mutational escape of #SARSCoV2 from monoclonal & polyclonal antibodies in terms of RBD epitope classes (biorxiv.org/content/10.1101/…). Provides useful framework for conceptualizing effects of individual and combined mutations. (1/n)
7
67
116
Richard G. James retweeted
18 Mar 2021
Finally, enjoyable part of project was getting to build on nice prior work by @cobarnes27 @bjorkmanlab @NussenzweigL @PaulBieniasz @theodora_nyc. We’ve read & enjoyed their papers on #SARSCoV2 antibodies, so appreciated opportunity to get to extend some parts of it. (11/n)
1
5
16